Schedule 13G ownership disclosure

Rapport Therapeutics Inc

Security class unavailable · CUSIP: 75383L102

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,665,682
Percent of class
7.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000769993-24-000277
Form type
SC 13G
Filer
GOLDMAN SACHS GROUP INC
CIK
CIK 886982
Filed
Jun 21, 2024
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub